Stemming from international academic research, CytoMEMS develops in the French Hauts-de-France region an innovative tool for the early diagnosis of cancer relapse, based on a simple blood test. This project already revolutionizes the field of biological analysis, drastically reducing both equipment costs and analysis times.
Would you like to edit the information on your profile page?
Oops! We could not locate your form.